Skip to main content
SpringerLink
Log in

Psychopharmaka im Kindes- und Jugendalter

  • Chapter
Handbuch der Psychopharmakotherapie

  • 2596 Accesses

Auszug

Psychopharmaka spielen bei der Behandlung psychischer Krankheiten von Kindern und, Jugendlichen eine große Rolle. Bere its in den Anfängen der wissenschaftlichen Kinder- und Jugendpsychiatrie im 19. Jahrhundert wurde psychotropen Substanzen in der Therapie viel Beachtung geschenkt. Nach dem Zweiten Weltkrieg war die deutsche Kinder- und Jugendpsychiatrie sehr stark pädagogisch und psychotherapeutisch geprägt, sodass biologische Aspekte lange Zeit nicht genügend Beachtung gefunden haben. Dies hat sich in den letzten Jahren grundlegend gewandelt. Nicht zuletzt durch die zunehmende Wichtigkeit der Evidenzbasierung der Therapie haben die Psychopharmaka erheblich an Bedeutung gewonnen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL (2002) Double blind, placebo controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 159(8): 1337–1346

    Article  PubMed  Google Scholar 

  • Arnold LE (2000) Methylphenidate vs., amphetamine: comparative review. J Attention Disord 3(4): 200–211

    Article  Google Scholar 

  • Averly PA, Lane I, Sykes J, Girdler NM, Steen N, Bond S (2004) An RCT pilot study to test the effects of intravenous midazolam as a conscious sedation technique for anxious children requiring dental treatment — an alternative to genral anaesthesia. Br Dent J 197: 553–558

    Article  Google Scholar 

  • Barkley RA, Fisher M, Smallish I, Fletcher K (2003) Does treatment of attention deficit/hyperactivity disorder with stimulants contribute to later drug use/abuse? A 13 year prospective study. Pediatrics 111: 97–109

    Article  PubMed  Google Scholar 

  • Barzman DH, DelBello MP, Adler CM, Stanford KE, Strakowski SM (2006) The efficacy and tolerability of quetiapine versus divalproxes for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s). J Child Adolesc Psychopharmacol 16(6): 665–670

    Article  PubMed  Google Scholar 

  • Bradley C (1937) The behavior of children receiving benzedrine. Am J Psychiatry 94: 577–585

    Google Scholar 

  • Brent DA (2004) Antidepressants and pediatric depression — The risk of doing nothing. N Engl J Med 551(16): 1598–1601.

    Article  Google Scholar 

  • Biederman J, Faraone SV, Monuteaux MC, Plunkett EA, Gifford J, Spencer T (2003) Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment. Pediatrics 111: 1010–1016

    Article  PubMed  Google Scholar 

  • Blederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA; Modafinil Study Group (2006) A comparison of oce-dailly and divided doses of modafinil in children with attention deficit hyperactivity disorder: a randomized double blind, and placebo controlled study. J Clin Psychiatry 67(5): 727–735

    Article  Google Scholar 

  • Birmaher B, Axelson DA, Monk K et al (2003) Fluoxetine for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 42(4): 415–423

    PubMed  Google Scholar 

  • Brown RT, Amler RW, Freeman WS et al and the Committee on Quality Improvement, Subcommittee on Attention Deficit/Hyperactivity Disoder (2005) Treatment of attention deficit/hyperactivity disorder: overview of evidence. Pediatrics 115: 749–757

    Article  Google Scholar 

  • Buitelaar JK, van der Gaag RJ, Cohen-Kettenis P, Melman CTM (2001) A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 62(4): 239–248

    Article  PubMed  CAS  Google Scholar 

  • Cameron OG, Thyer BA (1985) Treatment of pavor nocturnus with alprazolam. J Clin Psychiatry 46(11): 504

    PubMed  CAS  Google Scholar 

  • Campbell M, Andersen LT, Small AM (1993) Naltrexon in autistic children: behavioral symptoms and attentional learning. J Am Acad Child Adolesc Psychiatry 32(6): 1283–1291

    Article  PubMed  CAS  Google Scholar 

  • Campbell M, Kafantaris V, Cueva JE (1995) An update on the use of lithium carbonate in aggressive children and adolescents with conduct disorder. Psychopharmacol Bull 31: 93–102

    PubMed  CAS  Google Scholar 

  • Chang K, Saxena K, Howe M (2006) An open label study of lamotrigine adjunctor monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 45(3): 298–304

    Article  PubMed  Google Scholar 

  • Connor DF, Fletcher KE, Swanson JM (1999) A meta-analysis of clonidine for symptoms of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 38(12): 1551–1559

    Article  PubMed  CAS  Google Scholar 

  • Copur M, Arpaci B, Demir T, Narin H (2007) Clinical effectiveness of quetiapin in children and adolescents with Tourette Syndrome: a retrospective case-note survey. Clin Drug Investig 27(2): 123–130

    Article  PubMed  CAS  Google Scholar 

  • Donovan SJ, Stewart JW, Nunes EV et al (2000) Divalproex treatment for youth with explosive temper and mood lability: a double blind placebo controlled crossover design. Am J Psychiatry 157: 818–820

    Article  PubMed  CAS  Google Scholar 

  • Dunbar F, Kusumakar V, Daneman D, Schulz M (2004) Growth and sexual maturation during long-term treatment with risperidone. Am J Psychiatry 161(5): 918–920

    Article  PubMed  Google Scholar 

  • Ebert D, Krause J, Roth-Sackenheim C (2003) ADHS im Erwachsenenalter. Leitlinlen auf der Basis eines Expertenkonsensus mit Unterstützung der DGPPN. Nervenarzt 74(10): 939–946

    PubMed  CAS  Google Scholar 

  • Emslie GJ, Findling RL, Yeung PP, Kunz NR, Li Y (2007) Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry 46(4): 479–488

    Article  PubMed  Google Scholar 

  • Fegert J (2006) Stellungnahme zu fraglichen kardialen Risiken der Stimulanziengabe. Forum für Kinder-und Jugendpsychiatrie, Psychosomatik und Psychotherapie 16(1): 3–7

    Google Scholar 

  • Findling RL, Reed MD, Myers C et al (1999) Paroxetine pharmacokinetics in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry 38(8): 952–959

    Article  PubMed  CAS  Google Scholar 

  • Findling RI, McNamara NK, O’Riordan MA, Reed MD, Demeter CA, Branicky LA, Blumer JL (2003) An open-label study of St. John’s wort in juvenile depression. J Am Acad Child Adolesc Psychiatry 42(8): 908–914

    Article  PubMed  Google Scholar 

  • Findling R, Reimherr JM, McClellan JM et al (2004) Atypical antipsychotics in the treatment of children and adolescents. J Clin Psychiatry 65(Suppl): 3–44

    PubMed  Google Scholar 

  • Findling RL, Reed MD, O’Rlordan MA, Demeter CA, Stansbrey RJ, McNamara NK (2007) A 26 week open label study of quetiapine in children with conduct disorder. J Child Adolesc Psychopharmacol 17(1): 1–9

    Article  PubMed  Google Scholar 

  • Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellstrom B, Linnoila M (1985) Clomipramine treatment of childhood obsessive-compulsive disorder: a double-blind controlled study. Arch Gen Psychiatry 42: 977–983

    PubMed  CAS  Google Scholar 

  • Geller B, Reising D, Leonard HL, Riddle MA, Walsh BT (1999) Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry 38(5): 513–516

    Article  PubMed  CAS  Google Scholar 

  • Gerlach M, Banaschewski T, Warnke A, Rothenberger A (2003) Ist ein Parkinson-Syndrom als Spätfolge einer Methylphenidatbehandlung im Kindesalter möglich? Nervenheilkunde 22: 80–84

    Google Scholar 

  • Ginsberg LD (2006) A retrospective analysis of changing from alternative agents to carbamazepine extended release capsules in bipolar disorder. Ann Clin Psychiatry 18(Suppl 1): 31–34

    Article  PubMed  Google Scholar 

  • Graee F, Milner J, Rizzotto L, Klein RG (1994) Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 33: 372–376

    Article  Google Scholar 

  • Gutgesell H, Atkins D, Barst R et al (1999) AHA scientific statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs. J Am Acad Child Adolesc Psychiatry 38(8): 1047–1050

    Article  PubMed  CAS  Google Scholar 

  • Häßler F (1998) Psychopharmakotherapie bei geistig Behinderten. Psychopharmakotherapie 5: 76–80

    Google Scholar 

  • Hagino OR, Weller EB, Weller RA, Washing D, Fristad MA, Kontras SB (1995) Untoward effects of lithium treatment in children aged four through six years. J Am Acad Child Adolesc Psychiatry 34: 1584–1590

    Article  PubMed  CAS  Google Scholar 

  • Heger S, Trott GE, Meusers M et al (2006) Umstellung von einem unretardierten auf ein retardiertes Methylphenidatpräparat: Eine multizentrische offene Studie an Kindern mit ADHS. Z Kinder Jugendpsychiatr Psychother 43(4): 257–265

    Article  Google Scholar 

  • Heiser P, Remschmidt H (2002) Die selektiven Serotonin-Wiederaufnahmehemmer und die neueren Antidepressivasubstanzen in der Kinder-und Jugendpsychiatrie. Z Kinder Jugendpsychiatr 30(3): 173–183

    Article  CAS  Google Scholar 

  • Huss M, Lehmkuhl U (2002) Sind mit Methylphenidat therapierte Menschen einem erhöhten Missbrauchs-und Abhängigkeitsrisiko ausgesetzt? Forschungsbericht an das Bundes Institut für Arznelmittel und Medizinprodukte (BfArM) über die Ergebnisse der multizentrischen Studie Fo2.1-68503-200 ausgeschrieben im Deutschen Ärzteblatt Nr. 30 vom 28.6.1995

    Google Scholar 

  • Jensen PS, Garcia JA, Glied S et al (2005) Cost-effectiveness of ADHD treatments: findings from the multimodaltreatment study of children with ADHD. Am J Psychiatry 162(9): 1628–1636

    Article  PubMed  Google Scholar 

  • Jensen PS, Buitelaar J, Pandina GJ, Binder C, Haas M (2007) Management: of psychiatric disorders in children and adolescents with atypical antipsychotics. Eur Child Adolesc Psychiatry 16(2): 104–120

    Article  PubMed  Google Scholar 

  • Kane JN, Leucht S, Carpenter D, Docherty JP (2003) Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction, methods, commentary and summary. J Clin Psychiatry 54(Suppl 12): 5–19

    Google Scholar 

  • Kowatch RA, Suppes T, Carmody TJ et al (2000) Divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39(6): 713–720

    Article  PubMed  CAS  Google Scholar 

  • Kratochvil CJ, Vitiello B, Brent D, Bostic JQ, Naylor MW (2006) Selecting an antidepressant for the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 45(3): 371–373

    Article  PubMed  Google Scholar 

  • Krause KH, Krause J (2000) Ist Methylphenidat bei Komorbidität von Epilepsie und ADHS kontraindiziert oder nicht? Akt Neurologie 27: 72–76

    Article  Google Scholar 

  • Kutcher S, McKenzie S (1988) Successful clonazepam treatment of adolescents with panic disorder. J Clin Pharmacol 30(11): 1041–1048

    Google Scholar 

  • Labellarte MJ, Crosson JE, Riddle MA (2003) The relevance of prolonged QTc measurement to pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry 42(6): 642–650

    Article  PubMed  Google Scholar 

  • Lyon MR, Cline JC, Totosy de Zepetnek J, Shan JJ, Pang P, Benishin C (2001) Effect of the herbal extract combination Panax quinquefolium and Gingko biloba on attention defici thyperactivity disorder: a pilot study. J Psychiatry Neurosci 26(3): 221–228

    PubMed  CAS  Google Scholar 

  • Malone RP, Delaney MA, Luebbert JF, White MA, Biesecker KA, Cooper TB (1995) The lithium test dose prediction method in aggressive children. Psychopharmacol Bull 31: 379–382

    PubMed  CAS  Google Scholar 

  • McCracken JT (2002) Risperidone in children with autism and serious behavioral, problems. N Engl J Med 347(5): 314–321

    Article  PubMed  CAS  Google Scholar 

  • McDonald KJ, Young LT (2002) Newer antiepilleptic drugs in bipolar disorder: rationale for use and role in therapy. CNS Drugs 16(8): 549–562

    Article  Google Scholar 

  • Mrakotsky C, Masek B, Biederman J et al (2007) Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia. J Anxiety Disord, in press

    Google Scholar 

  • MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatments trategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56(12): 1073–1086

    Article  Google Scholar 

  • Murali H, Kotagal S (2006) Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate. Sleep 29(8): 1025–1029

    PubMed  Google Scholar 

  • Pliszka SR, Matthews TL, Braslow KJ, Watson MA (2006) Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45(5): 520–526

    Article  PubMed  Google Scholar 

  • Premont WP (2004) Childhood reactions to terrorism-induced trauma: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 43(4): 381–392

    Article  Google Scholar 

  • Raes A, Hoebeke P, Segaert I, van Laecke E, Dehoorne J, van de Walle J (2004) Retrospective analysis of efficacy and tolerability of tolterodine in children with overactive bladder. Eur Urol 45(2): 240–244

    Article  PubMed  CAS  Google Scholar 

  • Ratner S, Laor N, Bronstein Y, Weizman A, Toren P (2005) Six-week open-label Reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 44(5): 428–433

    Article  PubMed  Google Scholar 

  • Remschmidt H, Henninghausen K, Clement HW, Heiser P, Schulz E (2000) Atypical neuroleptics in child and adolescent psychiatry. Eur Child Adolesc Psychiatry 9: 1–19

    Article  Google Scholar 

  • Riddle MA, Bernstein GA, Cook EH, Leonhard HL, March JS, Swanson JM (1999) Anxiolytics, adrenergic agents, and naltrexone. J Am Acad Child Adolesc Psychiatry 38: 546–556

    Article  PubMed  CAS  Google Scholar 

  • Roessner V, Banaschewski T, Rothenberger A (2004) Therapie der Ticstörungen. Z Kinder Jugendpsychiatr Psychother 32(4): 245–263

    Article  PubMed  Google Scholar 

  • Ryan N (1990) Heterocyclic antidepressants in children and adolescents. J Child Adolesc Psychopharmacol 1: 21–30

    CAS  PubMed  Google Scholar 

  • Safer DJ, Zito JM, Gardner JF (2001) Pemoline hepatotoxicity and post-marketing surveillance. J Am Acad Child Adolesc Psychiatry 40(6): 622–629

    Article  PubMed  CAS  Google Scholar 

  • Salazar DE, Frackiewicz EJ, Dockens R et al (2001) Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults. Clin Pharmacol 41(12): 1351–1358

    Article  CAS  Google Scholar 

  • Schaeffer JL, Ross RG (2002) Childhood onseet schizophrenia: premorbid and prodromal diagnostic and treatment histories. J Am Acad Child Adolesc Psychiatry 41: 538–545

    Article  PubMed  Google Scholar 

  • Schlander M (2007) Long acting medications foor the hyperkinetic disorders: a note on cost-effectiveness. Eur Child Adolesc Psychiatry, in press

    Google Scholar 

  • Simeon JG, Ferguson HB, Knott V, Roberts N, Gauthler B, Dubois C, Wiggins D (1992) Clinical, cognitive and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry 31(1): 29–33

    Article  PubMed  CAS  Google Scholar 

  • Spencer TJ (2004) ADHD treatment across the life cycle. J Clin Psychiatry 65(Suppl 3): 22–26

    PubMed  CAS  Google Scholar 

  • Spencer T, Biederman J, Wilens T, Harding M, O’Donnell D, Griffin S (1996) Pharmacotherapy of attention deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35: 409–432

    Article  PubMed  CAS  Google Scholar 

  • Stahl SM (2003) Neurotransmission of cognition. Part 1: Dopamine is a hitchhiker in frontal cortex: norepinephrine transporters regulate sopamine. J Clin Psychiatry 64(1): 4–5

    PubMed  Google Scholar 

  • Trott GE (2004) Pharmacotherapeutische Besonderheiten im Kindesund Jugendalter. In: Nissen G, Fritze J, Trott GE (Hrsg) Psychtpharmaka im Kindes-und Jugendalter. Urban. & Fischer, München

    Google Scholar 

  • Trott G-E, Oehler KU (2006) Selektive Serotonin-Wiederaufnahmehemer bei Kindern und Jugendlichen. Psychoneuro 32(5): 275–278

    Article  Google Scholar 

  • Trott GE, Gold-Carl H, Badura F (1999) Klinik, Verlauf und Therapie von schizophrenen Psychosen mit sehr frühem Krankheitsbeginn. In: Naber D, Müller-Spahn F (Hrsg) Leponex. Pharmakologie und Klinik eines a typischen Neuroleptikums. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Vetro A, Scentistvangi I, Pallag L, Vargha M, Szilard J (1985) Therapeutic experience with lithium in childhood aggressivity. Pharmacopsychiatry 4: 121–127

    Google Scholar 

  • Van Gontard A, Lehmkuhl G (1996) Pharmakotherapie der Enuresis Z Kinder Jugendpsychiatr 24: 18–33

    Google Scholar 

  • Walitza S, Werner B, Romanos M, Warnke A, Gerlach M, Stopper H (2007) Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperativity disorder? Environ Health Perspect 115(6): 936–940

    Article  PubMed  CAS  Google Scholar 

  • Weiss MD, Wasdell MB, Bomben MM, Rea KJ, Freeman RD (2006) Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry 45(5): 512–519

    Article  PubMed  Google Scholar 

  • Wigal T, Greenhill L, Chuang S et al (2006) Safety and tolerability of mehylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry 45(11): 1294–1303

    Article  PubMed  Google Scholar 

  • Wilsher CR, Taylor EA (1994) Piracetam in developmental reading disorders: a review. Eur Child Adolesc Psychiatry 3(2): 59–71

    Article  Google Scholar 

Download references

Authors
  1. Götz-Erik Trott
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Max-Planck-Institut für Psychiatrie, Kraepelinstraße 2-10, 80804, München

    Florian Holsboer

  2. Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum der Rheinisch-Westfälischen Technischen Hochschule Aachen, Pauwelsstraße 30, 52074, Aachen

    Gerhard Gründer

  3. Ehemals: Psychiatrische Klinik und Poliklinik der Johannes-Gutenberg-Universität Mainz, Untere Zahlbacher Straße 8, 55131, Mainz

    Otto Benkert

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Trott, GE. (2008). Psychopharmaka im Kindes- und Jugendalter. In: Holsboer, F., Gründer, G., Benkert, O. (eds) Handbuch der Psychopharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68748-1_57

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68748-1_57

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20475-6

  • Online ISBN: 978-3-540-68748-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation